Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion type Assertion NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_head.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion description "[In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion evidence source_evidence_literature NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion SIO_000772 20882035 NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion wasDerivedFrom befree-20140225 NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion wasGeneratedBy ECO_0000203 NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.